Bladder Cancer

>

Latest News

Data from the POTOMAC trial evaluating durvalumab in NMIBC will be presented at a future medical meeting and shared with global regulatory authorities.
Durvalumab Combo Demonstrates DFS Improvement in High-Risk NMIBC

May 9th 2025

Data from the POTOMAC trial evaluating durvalumab in NMIBC will be presented at a future medical meeting and shared with global regulatory authorities.

Ileal Free Flap Urethroplasty May Remedy Devastated Bladder Outlet
Ileal Free Flap Urethroplasty May Remedy Devastated Bladder Outlet

May 7th 2025

FDA Issues Refusal to File Letter for Nogapendekin Alfa Inbakicept in NMIBC
FDA Issues Refusal to File Letter for Nogapendekin Alfa Inbakicept in NMIBC

May 5th 2025

UGN-102 Shows Durable Responses, Tolerability in Recurrent Low-Grade NMIBC
UGN-102 Shows Durable Responses, Tolerability in Recurrent Low-Grade NMIBC

May 3rd 2025

TAR-200 Improves Survival in BCG-Unresponsive, Papillary High-Risk NMIBC
TAR-200 Improves Survival in BCG-Unresponsive, Papillary High-Risk NMIBC

May 2nd 2025

More News